SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,465.14 -15.15
( -0.02%)

Global Indices

Nasdaq

50,945.10 -425.82
(-0.83%)

Dow Jones

7,674.56 -17.28
(-0.22%)

Hang Seng

66,863.07 1,381.80
(2.11%)

Nikkei 225

10,610.72 -25.99
(-0.24%)

Forex

USD-INR

95.97 0.01
(0.01%)

EUR-INR

108.89 -0.26
(-0.24%)

GBP-INR

126.98 -0.19
(-0.15%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.604918

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

44.84

86.16

EPS(TTM)

Face Value()

Div & Yield %

1.26

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	42.26	14.81	15.80	12.31	11.21	11.72
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	42.26	14.81	15.80	12.31	11.21	11.72
Other Income	0.00	0.47	0.32	0.02	0.00	0.00
Stock Adjustments	0.00	0.00	-0.21	-0.08	0.01	0.02
Total Income	42.26	15.28	15.91	12.25	11.22	11.74
EXPENDITURE :
Raw Materials	37.63	13.47	12.80	7.10	8.88	9.06
Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00	0.20
Employee Cost	0.74	0.30	0.80	0.78	0.85	0.91
Other Manufacturing Expenses	0.03	0.02	0.02	0.09	0.33	0.13
Selling & Administrative Expenses	0.67	0.23	0.36	1.33	0.40	0.61
Miscellaneous Expenses	0.00	0.00	0.80	0.37	0.00	-0.02
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	39.07	14.02	14.78	9.67	10.46	10.88
Operating Profit	3.20	1.26	1.15	2.60	0.77	0.86
Interest	0.07	0.85	0.79	0.65	0.51	0.44
Gross Profit	3.13	0.41	0.36	1.95	0.26	0.42
Depreciation	0.28	0.10	0.13	0.17	0.22	0.26
Profit Before Tax	2.85	0.31	0.23	1.78	0.04	0.16
Tax	0.88	0.07	0.05	0.53	0.01	0.04
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.03	0.01	0.01	0.01	0.00	0.00
Reported Net Profit	1.93	0.22	0.16	1.25	0.03	0.12
Extraordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	1.93	0.22	0.16	1.25	0.03	0.12
Adjustment below Net Profit	0.00	0.00	0.00	-4.61	0.00	0.00
P & L Balance brought forward	0.89	0.66	0.50	3.87	3.84	3.72
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	2.82	0.89	0.66	0.50	3.87	3.84
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.26	0.16	0.12	1.25	0.10	0.37
Earnings Per Share(Adj)-Unit Curr	1.26	0.16	0.12	1.25	0.10	0.37
Book Value-Unit Curr	18.60	16.53	16.37	10.73	22.41	22.31
Book Value(Adj)-Unit Curr	18.60	16.53	16.37	10.73	22.41	22.31

72,465.14 -15.15 ( -0.02%)

50,945.10 -425.82 (-0.83%)

7,674.56 -17.28 (-0.22%)

66,863.07 1,381.80 (2.11%)

10,610.72 -25.99 (-0.24%)

95.97 0.01 (0.01%)

108.89 -0.26 (-0.24%)

126.98 -0.19 (-0.15%)

0.61 0.00 (0.01%)